Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Kite CEO Christi Shaw On How Gilead Plans To Stay On Top In Cell Therapy

Jun 22 2021

• By Joseph Haas

3d illustration of T cells attacking a cancer cell — Manufacturing is key to Kite's cell therapy success, CEO Shaw says

Related Content

Gilead/Kite Pricing For Yescarta Undercuts Novartis's CAR-T Kymriah

Oct 19 2017

Keeping Track: US FDA Acts On 5 Novel Drugs: Approval For Fotivda, Pepaxto, Azstarys; CRLs For Defencath and Oral Paclitaxel

Mar 15 2021

Gilead Made Gains In Oncology, Though Virology Remains King

Feb 05 2021

Breyanzi Is Third To Market, But BMS’s First CAR-T Therapy Priced Above Competitors

Feb 08 2021

Kymriah Poised For Expansion In Follicular Lymphoma, Leveling The Field With Yescarta

Jun 02 2021

Gilead/Kite Gain Second CAR-T Approval With Tecartus, Price On Par With Their First

Jul 27 2020

Finance Watch: Investors Launch New SPACs After Initial Deals

Apr 09 2021

Veklury Still Keeping Gilead Above Water Amid Pandemic, Patent Expiries

Apr 29 2021

Gilead Writes Down Kite Buy As Yescarta Sales Flatten Out

Feb 05 2020

'A New TNBC Standard Of Care' – Trodelvy Could Vindicate Gilead’s $21bn Buyout

Sep 21 2020

Manipulating Metabolism: Lilly Links With UK Biotech Sitryx

Mar 31 2020

Gilead Calls Forty Seven Buyout Complementary To Kite, Other IO Efforts

Mar 02 2020

Gilead To Let Kite Fly Free; O’Day Says It Will Become Separate Business Unit

May 02 2019

Payers Must Brace For Coming Wave Of Cell And Gene Therapies

Oct 14 2019

Novartis Beats CAR-T Competitors To The Pricing Punch With Kymriah Approval

Aug 31 2017

'We Jumped' At Opportunity To Take On Pfizer's CAR-T Program, Allogene's Chang Says

Apr 04 2018

Could Automation Rescue CAR-T Manufacturing?

Mar 10 2021

Related Companies

Kite Pharma, Inc.

Gilead Sciences, Inc.

Shoreline Biosciences, Inc.

Novartis AG

Bristol Myers Squibb Company

Celgene Corporation

Amgen, Inc.

Immunomedics, Inc.

Forty Seven Inc.

Eli Lilly and Company

oNKo-innate Pty Ltd

HiFiBiO Therapeutics

Oxford BioTherapeutics

Additional Topics

Business Strategies Companies ImmunoOncology Regenerative Medicine Strategy ASCO Cancer BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window